Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2019JCI InsightOpen Access

Niclosamide repurposed for the treatment of inflammatory airway disease

View Full Paper
Ask AI
Bookmark
Share

Authors

ICInês CabritaCologne Excellence Cluster on Cellular Stress Responses in Aging Associated DiseasesRBRoberta Di BenedettoGlaxoSmithKline (France)RSRainer SchreiberThe University of Sydney

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cabrita et al. (2019) studied this question.

synapsesocial.com/papers/6a82e46477f6571b411e0f4ehttps://doi.org/10.1172/jci.insight.128414
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections2017 · 52 citations
  2. 2Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension2019 · 86 citations
  3. 3Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways2019 · 136 citations
  4. 4Expression and Function of Epithelial Anoctamins2010 · 220 citations